Long‐term 52‐week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of dermatology (1951) 2019-01, Vol.180 (1), p.211-212
Hauptverfasser:	Ighani, A., Georgakopoulos, J.R., Shear, N.H., Walsh, S., Yeung, J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - adverse effects Diarrhea - chemically induced Diarrhea - epidemiology Female Headache - chemically induced Headache - epidemiology Humans Long-Term Care Male Middle Aged Nausea - chemically induced Nausea - epidemiology Psoriasis Psoriasis - drug therapy Retrospective Studies Thalidomide - administration & dosage Thalidomide - adverse effects Thalidomide - analogs & derivatives Time Factors Treatment Outcome Weight Loss - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!